Quince Therapeutics appoints Brigette Roberts as CEO effective October 8, 2026
QNCX•Quince Therapeutics appointed Brigette Roberts as CEO effective October 8, 2026, according to an SEC filing.
1. CEO appointment
Quince Therapeutics appointed Brigette Roberts as CEO effective October 8, 2026, an SEC filing said.
